This study aims to report the willingness of different populations of high-risk couples to undergo preimplantation genetic diagnosis (PGD) for β-thalassaemia as an alternative to prenatal genetic diagnosis (PND), and the willingness of infertile couples to undergo PGD for aneuploidies. An information sheet and questionnaire presenting PGD and PND procedures were distributed to four population types: 54 high-risk couples for β-thalassaemia coming for their first PND (population A); 51 similar couples coming for their second or further PND without previous experience of therapeutic abortion (population B-na); 50 similar couples coming for their second or further PND with previous experience of therapeutic abortion for β-thalassaemia-affected fetus (population B-ab); and 74 infertile couples undergoing routine in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) (population C). Favourable first impressions towards PGD compared with PND were observed in all four populations in the following proportions: 79.6% population A; 76.5% population Bna; 92.0% population B-ab; and 96.0% population C. Willingness to undergo PGD for β-thalassaemia was as follows: 44.4% population A; 47.1% population B-na; and 72.0% population B-ab. We conclude that previous experience of PND for β-thalassaemia is a crucial point in the willingness to accept the PGD procedure, and that couples belonging to population B-ab are the most suitable to undergo PGD for β-thalassaemia. Some 96.0% of infertile couples in population C were ready to undergo PGD for aneuploidies.
Introduction
Haemoglobinopathies and β-thalassaemias are common major health problems in many Mediterranean countries (Kazazian 1936 © European Society for Human Reproduction and Embryology et al., 1990) . In Sicily, β-thalassaemia is present with an average gene frequency of 6% (about 300 000 carriers), and a heterogeneous distribution ranging from 10% in the south-east to 3-4% in the north or in the west of the island. From these data, a ratio of 1:270 couples may be considered to be at risk for β-thalassaemia with 66 new births per year (Caronia et al., 1989; Giambona, 1995) . β-Thalassaemia occurs in individuals who are homozygous for mutations (or deletions) in or around the β-globin gene cluster, and results in a marked decrease or absence of β-globin chain synthesis (Thein, 1993) . A couple of β-thalassaemia carriers has a 25% probability of having an affected baby with each pregnancy. Current therapies for β-thalassaemic patients are blood transfusion, iron chelation and allogenic bone marrow transplantation (Weatherall and Clegg, 1981; Rodgers and Rachmilewitz, 1995) , while chorionic villus sampling (CVS) (Brambati et al., 1987) , amniocentesis and genetic analysis by the polymerase chain reaction (PCR; Saiki et al., 1985; Mullis and Faloona, 1987) have made possible first-and second-trimester prenatal diagnosis by DNA analysis. Nowadays no treatment is available for β-thalassaemia in utero, and the only prevention is still pregnancy termination and its associated physical and emotional traumas. Kenyon et al. (1988) defined the grief following termination for fetal abnormality as being potentially similar to that following neonatal death. In our experience, after repeated selective pregnancy terminations for β-thalassaemia, couples often decide to renounce their desire to have a child.
Recent progress in in-vitro fertilization (IVF), gamete and embryo micromanipulations and molecular biology have now made possible preimplantation diagnosis of genetic diseases (Handyside et al., 1990; Harper, 1996) . In preimplantation genetic diagnosis (PGD), the embryos are genetically diagnosed and only embryos unaffected by a genetic disease are transferred into the mother's uterus. The principle is the initiation of a pregnancy from an unaffected embryo, thereby eliminating the risk of therapeutic pregnancy termination. To date, few studies report the attitude of potential users towards PGD. In North America, Pergament (1991) has observed that 50% of high-risk women with previous experience of prenatal diagnosis (PND) considered PGD to be a viable alternative and were prepared to undergo one or more treatments. In Scotland, Miedzybrodka et al. (1993) assessed women's attitudes and preferences to two methods: prenatal diagnosis for genetic disease and embryo and chorionic villus biopsy, by a postal questionnaire and found that a substantial number of women preferred embryo biopsy when the pregnancy had a genetic risk. According to Palomba et al. (1994) , who studied the degree of acceptability of PGD with blastocentesis in 180 Italian women at risk for β-thalassaemia awaiting CVS, the obstetric experience is an important factor in the reproductive choice, and women with previous therapeutic abortion found blastocentesis acceptable. Snowdon and Green (1997) described the attitudes to PGD of 245 men and women carriers of recessive disorders, compared with other reproductive options for carriers, such as PND, adoption and gamete donation. The majority of the investigated couples viewed the opportunity to avoid a termination of pregnancy as an important advantage of PGD, but PND remained the most useful reproductive option. Nowadays, PGD is becoming the subject of ethical debates in which it is sometimes accused of being 'eugenic' as it replaces the negative genetic selection of the routine PND with a new positive genetic selection in PGD (Testart and Sèle, 1995) . In order to understand the importance of PGD in the prevention of the transmission of genetic disease, we proposed a study of the expectancies of potential consumers of PGD for β-thalassaemia and aneuploidies by their direct testimony in a questionnaire. The studied populations were couples with different previous experiences of prenatal diagnosis or infertility.
Before initiating a programme of PGD for β-thalassaemia on a large scale in our reproductive medicine centre, we needed to know what type of population of high-risk couples were attracted to and willing to undergo this new genetic diagnosis. In order to understand patients' hopes and the best way in which PGD should be proposed to them, we submitted to three populations of patients a package composed of an information sheet and a questionnaire to be returned to the centre. We report here the views of four different populations of Sicilian couples towards PGD for β-thalassaemia in comparison with PND for β-thalassaemia (CVS). We explained to each of the couples that the questionnaire answers should be the result of discussion between the two partners on the possibility of becoming potential consumers of the PGD technique. The different populations were: population A, high-risk couples for β-thalassaemia offspring coming for their first PND; population B, high-risk couples for β-thalassaemia offspring before second or further PND with (population B-ab) or without (population B-na) previous experience of selective termination pregnancy termination for β-thalassaemia; population C, infertile couples from the reproductive medicine centre undergoing IVF or intracytoplamic sperm injection (ICSI) treatment.
Materials and methods
We presented an information sheet (Appendix I shows a translated version) and a questionnaire to each population group. The information sheet was designed to be as unbiased as possible and included the protocol of PND and PGD procedures for β-thalassaemia, the objectives of both techniques, and a comparison between them. We gave no percentage of pregnancy loss/success rate because PGD is still an experimental method. At the end of the information sheet we added a glossary of the main scientific words. The questionnaire was anonymous, and one copy was submitted per couple. The package (information sheet ϩ questionnaire) was given to four different populations divided according to the following criteria:
Population A (n ϭ 54): carrier couples coming from all over Sicily to the β-thalassaemia centre in Palermo for their first PND for β-1937 thalassaemia. The package was given to the couples before the CVS and handed back to the doctor during the consultation to discuss the CVS result.
Population B: carrier couples coming to the β-thalassaemia centre for their second or further PND for β-thalassaemia. The package was given before the CVS and handed back to the doctor during consultation to discuss the PND result. Population B was subdivided into: population B-na (na ϭ 'no abortion') for the couples coming for their second or further PND whose fetuses had been affected by β-thalassaemia in their previous PND (n ϭ 51); and population B-ab (ab ϭ 'abortion') for the couples coming for their second or further PND and who had undergone a selective termination of pregnancy for β-thalassaemia-affected fetuses (n ϭ 50). An important point was that, included in population B-ab, were those couples who knew they were β-thalassaemia carriers, having already had an affected child and who had come for their first or further PND.
Population C: non-high-risk but infertile couples undergoing IVF or ICSI treatment in our reproductive medicine centre. The package was given during the hormonal stimulation and handed back before the pregnancy test result (n ϭ 74).
For populations A and B, we worked in collaboration with the regional thalassaemia centre 'Piera Cutino', V.Cervello Hospital Centre in Palermo. Population C comprised patients from the reproductive medicine centre in the 'Vittorio Emanuele' Hospital, Catania.
The questionnaire was divided into three parts. The first part treated the social status (age, civil status, religion) of both members of the couple. The second part investigated the β-thalassaemia history of the couple, thus permitting their classification into different populations. The third and final parts were designed to obtain the following information: (i) the couple's first impressions after reading the information sheet on the current status of PGD for β-thalassaemia as opposed to PND for the same disease; (ii) the advantages and disadvantages of PGD for β-thalassaemia; (iii) the couple's willingness to undergo PGD for β-thalassaemia in the case of future pregnancy plans (in population C, we asked the infertile couples to express their willingness to undergo PGD for aneuploidy); and (iv) the couple's comments about the PGD procedure (advantages and disadvantages of the technique and willingness to undergo it) and the presentation of the package.
Frequency table analyses and analyses of bivariate association by contingency table (cell marginal and partial distribution analysis) were used for the statistical analysis of the results.
Results

Characteristics of groups
Age and civil status of the different groups are shown in Table I . Nearly 100% of populations B and C and 88.9% of population A were married; 97% of members of the couples were catholic, 1.3% had no religion, and 1.7% belonged to other religions. The mean (Ϯ SD) age of the women was 29.3 Ϯ 3.1 (range 18-42) years for the women; that for men was 33.1 Ϯ 3.8 (range 21-47) years. Population A was the younger population, with mean age then rising sequentially to populations B-na, B-ab and C.
β-Thalassaemia history of the couples
All couples in populations A and B knew that they were β-thalassaemia gene carriers. Women and men of populations A, B-na and B-ab found themselves to be carriers in the following manner: 23.2% (n ϭ 36) of women and 16.1% (n ϭ 25) of Table I . First impressions of PGD for β-thalassaemia as opposed to PND Impression Populations men by their family history; 42.6% (n ϭ 66) of women and 47.1% (n ϭ 73) of men by blood screening; 29.7% (n ϭ 46) of women and 32.2% (n ϭ 50) of men by routine pregnancy blood screening. A total of seven couples (4.5%, all in population B-ab) realized that they were carriers after having a β-thalassaemic child. Five couples in population C had a carrier member.
All couples in population B had had at least one experience of PND for β-thalassaemia and six couples in population Bab had reached three PND, while none of the couples in the other populations had undergone PND for any genetic disorder. Of the seven precedent couples of population B-ab who had found themselves to be β-thalassaemia carriers by having an affected child, three had undergone a subsequent selective pregnancy termination for a β-thalassaemic fetus and were coming for their second or further PND, two were coming for their second PND without previous experience of selective pregnancy termination, and two were coming for their first PND. Inclusion of the last four families in population B-ab might be criticized, as they had never experienced a therapeutic abortion; however, we considered that couples who found themselves to be β-thalassaemia carriers by having a β-thalassaemic child were characteristically closer to population B-ab couples as both have (or have had) a β-thalassaemic child (or fetus) at some time and thus all had experience of β-thalassaemia.
Five couples in population A (10.2%) had one healthy child before discovering that both partners were β-thalassaemia carriers. All couples in the B-na population had one (80.4%) or two children (19.6%); 18 couples in population B-ab had no children (32.0%), and 25 couples had one non-β-thalassaemic child (50.0%). Seven couples in population B-ab had a β-thalassaemic child (14.0%), and no couples in population C had a child.
First impressions of PGD for β-thalassaemia compared with PND
Of all couples questioned, 86.9% considered PGD for β-thalassaemia to be a superior technique to PND, 3.9% considered the two techniques to be equivalent, and 8.3% preferred PND. These results could be subdivided into two groups on the basis of the similarities of their answers. The first group 1938 consisted of populations A and B-na, who had similar first impressions towards PGD, with 79.6% and 76.5% of populations A and B-na, respectively, feeling PGD to be an excellent alternative, a better technique, or slightly better than PND. The second group comprised populations B-ab and C; 92.0% of the former and 96.0% of the latter considered PGD to be an excellent alternative, a better technique, or slightly better than PND. The details of these results are shown in Table I .
Advantages and disadvantages of PGD for β-thalassaemia compared with PND
We asked the different populations to classify the advantages and the disadvantages of PGD for β-thalassaemia according to importance. We defined three main advantages of PGD over PND, two of which had a direct implication to the couple's personal experience: the elimination of anxiety and stress while waiting for the PND result, and the elimination of the psychophysical trauma during selective pregnancy termination in the case of β-thalassaemic fetus diagnosis. The other advantage was linked directly to the β-thalassaemic fetus itself and concerned its loss (death) in the case of positive PND. The disadvantages of PGD concerned the IVF procedure: IVF for fertile couples, ovarian stimulation, oocyte retrieval and the failure to become pregnant after transfer of non-β-thalassaemic embryos. The results of these findings are listed in Table II .
Couples in populations B-na, B-ab and C considered that the greatest advantage of PGD was to avoid selective pregnancy termination in the case of positive PND (first choice, 64.7, 56.0 and 77.0%, respectively). This opinion was shared in part by couples in population A (first choice 50.0%), who also felt that eliminating the psychophysical trauma of couples during abortion was of particular importance (first choice 40.7%). All populations considered the fact of avoiding anxiety and stress while waiting for the result of PND as the third advantage (67.2%). Opinions were divergent regarding the advantage that PGD offers by eliminating the psychophysical trauma of couples during abortion: population A thought it important (first choice 40.7%), while populations B-na, B-ab and C placed it in second or third position.
Couples in populations A, B-na and B-ab all agreed that the IVF procedure, ovarian stimulation or oocyte retrieval were minor disadvantages of PGD, while the possible failure to obtain a pregnancy after non-β-thalassaemic embryo transfer was considered the greatest disadvantage (first choice 63.0, 54.9 and 58.0% for populations A, B-na and B-ab, and 73.0% for population C). Couples in population C did not consider IVF procedure to be an inconvenience (first choice 6.7%), but had some reservations about ovarian stimulation (second choice 29.7%).
Willingness to undergo PGD for β-thalassaemia or aneuploidy versus PND We asked couples in different populations to judge whether PND or PGD was more acceptable for β-thalassaemia (or aneuploidy for population C). The results are shown in Table III . Although all four populations showed an overall preference for PGD, populations A and B-na were more divided between the two techniques (46.3% and 43.1% acceptability), while populations B-ab and C clearly favoured PGD for β-thalassaemia or aneuploidy (68.0% and 82.4%, respectively).
Once the acceptability of PGD had been ascertained, couples were asked if they would be willing to undergo PGD in the case of a planned pregnancy. The results are shown in Table IV ; populations A and B-na were divided in agreeing to undergo PGD, while populations B-ab and C were strongly in favour of PGD. Couples in population A, although in general considering PGD for β-thalassaemia to be more acceptable than PND, were divided in their willingness to undergo PND (48.2%) or PGD (44.4%) for β-thalassaemia in the case of a planned pregnancy. The other three populations showed either a slight increase (populations B-na and B-ab) or a sizeable increase (population C) in willingness, in comparison with the acceptability. The degree of willingness to undertake PGD for β-thalassaemia (47.1%) for couples in population B-na was equivalent to the degree of acceptability of PGD (43.1%), while 35.3% of couples in population B-na remained unfavourable, as did 28% of couples who had already undergone a selective termination of pregnancy. Couples in population B-ab who had considered PGD to be the more acceptable technique (68.0%) and two couples who had considered the techniques equivalent were willing to undergo the technique (final 72%). Couples in population C who had initially hesitated between the two techniques were eventually willing to undergo PGD for aneuploidies, and 94.6% of population C were willing to undergo it for aneuploidies in the case of a planned pregnancy.
Couples willing to undergo PGD for β-thalassaemia (or aneuploidy in population C) in the case of a planned pregnancy were asked to define the factor determining their choice; results are shown in Table V .
The possibility of planning a pregnancy with certainty that the fetus would not have β-thalassaemia or any chromosomal abnormalities was viewed as a determining factor by populations A, B-ab and C. Population B-na was more concerned about the anxiety and stress while waiting for PND result (second choice 58.3%), while the other populations did not consider this a determining factor. The psychophysical trauma during abortion was feared somewhat more by population Bna (first choice 54.2%), while populations A, B-ab and C had divergent opinions on this point. We would like to underline the testimony of the seven couples in population B-ab who already had a β-thalassaemic 1940 child. Three of these thought that PGD for β-thalassaemia was an excellent alternative to PND, three judged PGD to be a better technique, and one couple found PGD slightly better. The opinions were divided regarding the disadvantages of PGD, but five couples agreed that the main advantage of this technique was to avoid abortion following positive DNP; the other two couples attached some importance to the elimination of anxiety and stress while waiting for the PND result. Four of these seven couples were willing to undergo PGD for β-thalassaemia, their determining factor being the possibility of planning the pregnancy with certainty that the fetus would not have β-thalassaemia. Two couples renounced the idea of having more children and refused any kind of diagnosis. The couple that judged PGD to be a slightly better technique than PND were not willing to undergo PGD in the case of a planned pregnancy.
It is important to underline that all willing couples in populations A, B-na and B-ab also agreed to undergo a control PND by CVS for β-thalassaemia and aneuploidy following PGD for β-thalassaemia.
As the questionnaires were compiled by both members of the couple, we also asked whether one member of the couple was more willing to undergo PGD for β-thalassaemia (or aneuploidy) than the other. From Table VI , it can be seen that male and female opinions were not significantly different towards PGD, with women more favourable (69.9%) than men (65.5%).
All couples questioned found the package (information sheet ϩ questionnaire) clear and easy to understand.
No statistical analyses were applied to the data as it was felt that the number of cases was too low to apply inferential statistical tests of hypothesis such as analysis of variance or χ 2 association. Therefore, data were analysed by descriptive statistical criteria, i.e. frequency table analysis and bivariate association.
Discussion
New advances in IVF, gamete and embryo manipulations (Palermo et al., 1992; Tarin and Handyside, 1993; Van Steirteghem et al., 1993) and molecular biology have now made the application of preimplantation genetic diagnosis (or PGD) for β-thalassaemia possible for a high-risk population such as Sicilian couples (average gene frequency 6% of the whole island population). With the aim of understanding the expectancies of potential consumers, this study was organized in order to relate the views and willingness of different populations of Sicilian couples towards PGD for β-thalassaemia in comparison with prenatal diagnosis (or PND) for the same disease, the couples being grouped into four populations.
The initial observation of this study was that 67.7% of questioned couples agreed to undergo PGD for genetic reasons.
The first population (A) comprised β-thalassaemia carrier couples coming for their first PND. Based on their first impressions, 79.6% considered PGD for β-thalassaemia a better technique than PND, though after considering the technique's advantages and disadvantages only 46.3% thought PGD more acceptable; ultimately, 44.4% of population A were prepared to undergo PGD in the case of a planned pregnancy. Such a high percentage is remarkable in couples who have never undergone any form of diagnosis. Indeed, in their free comments (data not shown), unwilling couples of population A revealed that they would be prepared to undergo PGD if PND did not satisfy their future requirements. They considered PGD to be more suitable for sterile couples, and reacted negatively to the 'unnatural' method of conception and the possible failure to become pregnant after non-β-thalassaemic embryo transfer.
Some 76.5% of the carrier couples coming for their second or further PND procedure for β-thalassaemia with no previous selective pregnancy termination experience (population Bna) were initially attracted to PGD for β-thalassaemia, but ultimately only 47.1% of them were prepared to undergo PGD. We note that while the willingness of this population was similar to that of population A, their motivations were different. Population A felt that planning a pregnancy with assurance that the fetus would not have β-thalassaemia, thereby avoiding the death of an affected fetus, was a determining factor, while population B-na was more concerned with the couple's own experience and considered elimination of the psychophysical trauma of the abortion to be particularly important. These couples were less concerned with the anxiety and stress of waiting for the results of PND. This leads to the conclusion that PND, even without previous precedent experience of selective pregnancy termination, is an unpleasant experience that is both stressful and damaging to the couples.
Couples coming for their second or further PND procedure for β-thalassaemia either with previous experience of selective pregnancy termination for β-thalassaemia or with an affected child (population B-ab), had a better first impression towards PGD than PND for β-thalassaemia in 92% of cases (Table I) . According to the question of acceptability of PGD versus PND (see Table III ), 68% of these couples thought PGD to be a more acceptable technique than PND, while 22% thought the two techniques equally valid. Some 72% of the couples in population B-ab would be willing to undergo PGD (Table IV) . In these answers, it must be taken into consideration that some of the interrogated couples in favour of PGD for β-thalassaemia also declared that they did not want more children and were not prepared to undergo any kind of diagnosis. The high percentage of willing couples in the B-ab population leads to the conclusion that selective pregnancy termination after positive PND for β-thalassaemia is a major determining factor in these couples' search for a more acceptable alternative. The couples did not want to face the experience of selective pregnancy termination again. Regarding the determining factor of choice for the couples willing to undergo PGD, we note they attached different levels of importance to the psychophysical trauma endured during the experience of the abortion, while 94.1% of them considered the avoidance of anxiety and stress while waiting for PND result as the third factor, and 73.5% underlined the importance of planning a pregnancy with assurance that the fetus did not have β-thalassaemia. These two percentages led to the conclusion that the essential aim for these couples was to give life to an unaffected child, but without risking the termination of an affected fetus. In fact, it is clear that while PND would only allow the couple to avoid having a β-thalassaemic child by the interruption of an affected pregnancy, the primary objective of PGD is to institute a nonaffected pregnancy by the transfer of non-β-thalassaemiaaffected embryos. In other words, PND tends to eliminate a pregnancy (negative selection), while PGD tends to obtain a pregnancy (positive selection). The free comments of the Bab couples showed that they had great faith in this new diagnostic technique.
To understand the effect that the couples' experiences have on their willingness to undergo PGD for β-thalassaemia it would be interesting to have the testimony of couples coming for a β-thalassaemia screening, prior to any pregnancy plans, and to follow their feelings towards PGD during their future reproductive and PGD experiences. This would show if PGD lives up to the couple's expectations and enable evaluation of the consequences of the technique without interference of the previous experience of PND. It would also be interesting to evaluate the effects on a fertile couple of having a child by IVF.
We chose the population of infertile non-β-thalassaemia carrier couples (population C) as testimonies for the first impressions of PGD for β-thalassaemia, and tested their willingness to undergo PGD to detect a chromosomally aneuploid fetus. Some 95.9% of these couples had a positive impression of PGD for β-thalassaemia as opposed to PND, and 96.0% were ready to undergo PGD for aneuploidies. These couples had a very personal assessment of the 'price' of having a child because of their difficulties in reproduction, and they were the only ones with experience of the real emotive damages that can be felt by a couple in all the steps of IVF. According to their free comments, they were very happy about the progress of the new technology and considered PGD for β-thalassaemia as a morally and ethically acceptable technique. As with populations A and B-ab, the couples of population C regarded the possibility to plan a pregnancy with assurance that the fetus would be safe as a determining factor in their choice of PGD. Of course, selective pregnancy termination would have a heavier effect on these couples than the others: it would turn the great victory of becoming pregnant against overwhelming odds into an even greater tragedy. PGD for aneuploidies would represent for infertile couples an easy way of transferring a healthy embryo without any additional emotional cost to the couple. Across the range of couples who were willing or unwilling to undergo PGD, it was interesting to note that few of the investigated couples (Table II) considered the IVF procedure to be an important disadvantage of PGD. However, 63.3% of the whole population stated that the essential weak point of PGD was the possible failure to conceive, which remains the drawback of assisted reproductive techniques (Edwards, 1995) .
Even if we do not observe a significant difference in the willingness to undergo PGD between men and women in this study (Table VI) , it would be useful to determine the differences of personal feelings between the two partners during their 'consummation' of PGD.
We can assume that 86.9% of all the couples had a good first impression of PGD for β-thalassaemia and 67.7% of them accepted the technique. The first conclusion of this investigation is that PGD for β-thalassaemia is well accepted among carrier couples with a progressive preference for this technique over PND across the populations A, B-na and B-ab. This increasing interest in PGD could easily lead to the conclusion that PND does not fully satisfy couples' long-term requirements and PGD is seen as a valid alternative. This study shows that previous experience of PND for β-thalassaemia is a crucial point in the willingness to accept the PGD procedure, and reveals that the most attracted and willing population to undergo PGD for β-thalassaemia includes couples who have already experienced PND and selective pregnancy termination for this disease (population B-na). For all couples, the main advantage of PGD is to avoid the death of the affected fetus with the selective pregnancy termination. Of course, this ethical problem is not totally resolved with PGD, because the technique does not avoid the conception of β-thalassaemic pre-embryos but only their development to the fetus stage. We consulted one young couple who had had a β-thalassaemic-affected fetus diagnosed after PND, and had decided to maintain the pregnancy, who refused the idea of PGD for β-thalassaemia, and only accepted the notion of pre-conceptional diagnosis. In principle, it could be simplistic to say that the β-thalassaemia carrier patients would like an easy diagnostic technique that can ensure them a child, but without leaving any resentment for the death of their offspring. It should be noted that nearly all the infertile population would be willing to undergo PGD procedure for aneuploidy.
We would also like to contribute to the current debate on PGD and eugenism (Testart and Sèle, 1995; Fiddler and Pergament, 1996; Handyside, 1996) . We believe that if PGD is proposed as an alternative to PND in the same genetic conditions (for example, β-thalassaemia or aneuploidy), it will be preferred by those potential consumers who see in it the possibility of instituting a pregnancy with an unaffected fetus, and eliminating the eventual abortion of an affected fetus. In this way, there can be no doubt that the positive genetic selection of PGD (using the terms of Testart and Sèle) helps the patient. Until now, PND represented the 'verdict of life or death' for their offspring, while PGD allows the feeling of hope to conceive a healthy embryo and future fetus. Of course, the reactions of the fertile couples that fail to conceive after PGD still requires investigation. Furthermore, it seems that PND does not satisfy all the expectations of β-thalassaemia carrier couples, but we do not know yet if PGD will. We consider it useful and important for the patient to be offered different kinds of diagnoses (prenatal, preimplantation or preconceptional genetic diagnosis), and consequently to apply the method that is more suited to their needs, while awaiting the applicability of gene therapy.
By the summary of the world data, pregnancy rates for couples undergoing PGD are higher than for infertile couples undergoing normal IVF (Harper, 1996) . Once the low implantation rate of IVF procedure has been overcome (Edwards, 1995) and misdiagnosis has been definitively eliminated for the PGD procedure (Ray and Handyside, 1996) , we are likely to find that many Sicilian couples may be willing to undergo PGD for β-thalassaemia.
When these eggs are mature they are retrieved under local anaesthetic and put together with the spermatazoa of the male partner in laboratory conditions. After 72 h the fertilized eggs become embryos comprised of several cells.
Cell extraction
One cell is extracted from each embryo. It is important to note that this extraction in no way damages the normal development of the embryo.
Genetic analysis of extracted cells and identification of affected embryos
The extracted cell holds the same genetic code as the embryo from which it is extracted. Whether the cell is β-thalassaemiaaffected is ascertained through the use of the same genetic examination used in prenatal diagnosis. This analysis, known as 'preimplantation diagnosis', allows for the identification of healthy embryos. One, two or three of the healthy embryos are transferred into the female partner's uterus by a very simple operation similar to that of a routine gynaecological examination.
The application of this new diagnosis technique necessitates a 14-day period after the transfer of the healthy embryos before undergoing a routine blood pregnancy test.
Aims of preimplantation diagnosis for β-thalassaemia and comparison with prenatal diagnosis
The primary aim of preimplantation diagnosis, and prenatal diagnosis, is to eliminate the risk of having a β-thalassaemic child for high-risk couples: more than 1100 transfusiondependent patients are currently suffering from the disease in the island, and 6.5% of the Sicilian population are known to be carriers of the disease.
The second aim of preimplantation diagnosis is that of eliminating the 12-week period which a couple with a high risk of producing a β-thalassaemia-affected child must normally wait before undergoing prenatal diagnosis. The high possibility (25%) that prenatal diagnosis will indicate a β-thalassaemiaaffected fetus can create extreme anxiety and great psychological and physical stress for the couple during this period.
The third aim of preimplantation diagnosis is that of eliminating the trauma of an eventual voluntary abortion resulting from prenatal diagnosis of a β-thalassaemia-affected fetus. Such traumas can be so serious as to negatively influence the couple's reproductive behaviour. PGD eliminates the eventual risk of selective pregnancy termination and favours pregnancy plans by assuring that the child will be non-β-thalassaemic.
